Skip to main content
. 2018 Jun 30;9:2447. doi: 10.1038/s41467-018-04907-0

Fig. 5.

Fig. 5

Impact of CLDN18-ARHGAP fusion on chemotherapy treatment outcomes.Survival curves with/without chemotherapy treatment in patients without CLDN18-ARHGAP fusion (a) or fusion burden (b) at stage III and IV. P value was estimated by using Cox model